PHILIPS HEADQUARTERS CAMBRIDGE

FDA Regulatory Profile

PHILIPS HEADQUARTERS CAMBRIDGE appears in FDA public data with 4 recalls, 0 510(k) clearances, 0 FDA inspections, and 0 compliance actions on record. Its most recent recall (Z-1625-2023, Class II) was initiated on April 12, 2023.

Summary

Total Recalls
4
510(k) Clearances
0
Inspections
0
Compliance Actions
0

Recent Recalls

NumberClassProductDate
Z-1625-2023Class IIIncisive CT Plus -Whole-body computed tomography (CT) X-Ray System Model Number: 728149 (OUS)April 12, 2023
Z-1623-2023Class IIIncisive CT- Whole-body computed tomography (CT) X-Ray System Model Number: 728143 (OUS)April 12, 2023
Z-1624-2023Class IIIncisive CT Power- Whole-body computed tomography (CT) X-Ray System Model Number: 728148 (OUS)April 12, 2023
Z-1622-2023Class IIIncisive CT- whole-body computed tomography (CT) X-Ray System Model Number: 728144April 12, 2023